Virpax PharmaceuticalsVRPX
VRPX
$0.7400
2.12%
Market Cap: $3.62M
About: Virpax Pharmaceuticals Inc is a preclinical stage biopharmaceutical company. The company is focused on developing pharmaceutical product candidates for pain management. Its product portfolio includes Topical metered-dose spray; Liposomal in Hydrogel encapsulation; and Enkephalin Intranasal spray.
Employees: 7
0
Funds holding %
of 6,710 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
93% more capital invested
Capital invested by funds: $6.5K [Q1] → $12.6K (+$6.07K) [Q2]
33% more funds holding
Funds holding: 6 [Q1] → 8 (+2) [Q2]
0.72% more ownership
Funds ownership: 0.17% [Q1] → 0.89% (+0.72%) [Q2]
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Research analyst outlook
1 Wall Street Analyst provided 1 year price targets over the past 3 months
Low target
$3
305%
upside
Avg. target
$3
305%
upside
High target
$3
305%
upside
1 analyst rating
1 positive
100%
0 neutral
0%
0 negative
0%
Maxim Group Naz Rahman 27% 1-year accuracy 3 / 11 met price target | 305%upside $3 | Buy Upgraded | 19 Jul 2024 |